Mucormycosis COVID-19 Coinfection

Nayak, Niranjan

doi:10.31632/ijalsr.2022.v05i01.001

Cited by 3 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This study aims to learn more about the psychological effects of the pandemic on nursing students (Kishore, Kunjukunju, & Yusof, 2022). COVID-19 coinfection can be life threatening for patients (Nayak, 2022).…”

Section: Figure 1: the Mean Magnitude (And Standard Deviation) Increa...mentioning

confidence: 99%

Myopia Progression During COVID19 Pandemic at a Tertiary Care Hospital

Shah¹,

Ullah²,

Khan³

et al. 2022

MJMR

View full text Add to dashboard Cite

Purpose: The lockdown due to the COVID-19 pandemic lead to many countries implementing a population lockdown. This study was designed to investigate the myopic changes that occurred during lockdown due to the COVID19 pandemic in Pakistan. Methods: A prospective, cross-sectional study, was conducted on patients presenting to the out-patients department with symptoms suggesting a refractive problem. Subjects with a Mean Spherical Equivalent (MSE) level of myopia of at least -0.50DS were included. The second group of subjects that had emmetropia (MSE between -0.25DS and +0.25DS) was recruited. All subjects (including adults) underwent cycloplegic refraction and used objective and subjective techniques, to exclude any pseudo-myopia due to accommodation. Results: A total of 900 subjects were enrolled from 4 to 24 years. The myopia group consisted of 473 subjects (256 females) and the emmetropia group consisted of 427 subjects (224 females). There was no statistical difference in the ages of the groups. Both groups showed an increase in their level of myopia, which was statistically higher in the emmetropic group (p<0.001). Further analysis was conducted, splitting the subjects into four age groups: 4-8 years; 9-12 years; 13-19 years; and 19-24 years. All age groups showed an increase in the magnitude of myopia, with the oldest age group showing the least increase, which was statistically significant (p<0.005). Conclusions: An increase in the magnitude of myopia was seen in all subjects and across all age groups, but more so in the younger subjects.

show abstract

Section: Figure 1: the Mean Magnitude (And Standard Deviation) Increa...mentioning

confidence: 99%

Myopia Progression During COVID19 Pandemic at a Tertiary Care Hospital

Shah¹,

Ullah²,

Khan³

et al. 2022

MJMR

View full text Add to dashboard Cite

show abstract

Beyond the Virus: Exploring Coinfections in the COVID-19 Pandemic

Rasizadeh,

Milani,

Aghbash

et al. 2023

TOMICROJ

View full text Add to dashboard Cite

The global impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the COVID-19 pandemic, cannot be understated. Amidst the relentless focus on this viral adversary, we must not lose sight of an equally formidable challenge – the lurking threat of bacterial coinfections that can exacerbate morbidity and mortality. Various factors, including ICU admissions, age demographics, microbiota disturbances, and empirical antibiotic use, contribute to the specter of bacterial coinfections. Respiratory tract coinfections, often featuring Streptococcus pneumoniae, precede bacteremia and urinary tract involvement. However, the bacterial landscape in COVID-19 coinfections is a diverse tapestry with regional and institutional variations. Unlike its viral counterparts, COVID-19 exhibits a lower incidence of bacterial coinfection, underscoring the urgency of judicious antibiotic administration to curb the looming threat of antimicrobial resistance. Pandemics have historically witnessed an upsurge in coinfection-related morbidity and mortality. This comprehensive review delves into the multifaceted realm of bacterial, viral, and fungal coinfections amidst the COVID-19 pandemic. We scrutinize their impact on the respiratory and urinary tracts, blood, microbiota, and the ominous emergence of drug-resistant microorganisms. In conclusion, we explore nuanced treatment strategies in the quest for effective pandemic management.

show abstract

THE CONTINUOUS EVOLUTION OF SARS-CoV-2: HOW CLOSE ARE WE TO THE END OF THE PANDEMIC?

KILBAŞ

Altındiş

2022

Journal of Biotechnology and Strategic Health Research

View full text Add to dashboard Cite

Pandeminin başlangıcından bu yana SARS-CoV-2 genomunun dizilenmesi, viral evrimin anlaşılmasına katkıda bulunmakta ve COVID-19 hastalığının kökenleri ve yayılmasına yönelik genomik epidemiyoloji araştırmalarına olanak sağlamaktadır. SARS-CoV-2, diğer RNA virüslerine benzer şekilde sürekli mutasyona uğramakta ve yeni varyantlar ortaya çıkmaktadır. SARS-CoV-2 varyantları arasında, bunların yalnızca bir kısmı, daha bulaşıcı oldukları ve daha ağır hastalıklara neden oldukları için halk sağlığı açısından risk oluşturabilmektedir. Bu mutasyonlar virüse seçici bir avantaj sağlayabilirler. Varyantlar insan sağlığı açısıdan daha riskli hale geldiğinde, endişe verici varyantlar (VOC) olarak adlandırılmaktadırlar. 2021 yılının Kasım ayına kadar pandeminin hâkimi olan Delta varyantı, hastaneye yatış ve ölüm riskinin artmasına neden olmuştur, ancak mevcut aşılar bu varyanta karşı etkilidir. Son varyant olan Omicron, artan bulaşabilirlik ve azalmış antikor duyarlılığı ile karakterize edilmektedir. Bu derlemede, SARS-CoV-2 varyantlarının bulaşıcılıkları, hastalığın şiddeti ve bağışıklık duyarlılıkları ile ilgili bilgiler incelenecektir.

show abstract

Mucormycosis COVID-19 Coinfection

Cited by 3 publications

References 10 publications

Myopia Progression During COVID19 Pandemic at a Tertiary Care Hospital

Myopia Progression During COVID19 Pandemic at a Tertiary Care Hospital

Beyond the Virus: Exploring Coinfections in the COVID-19 Pandemic

THE CONTINUOUS EVOLUTION OF SARS-CoV-2: HOW CLOSE ARE WE TO THE END OF THE PANDEMIC?

Contact Info

Product

Resources

About